​“HPV Vaccination is Cancer Prevention” Training

Pre-test

Please compete the pre-test to view the video.

Step 1 of 2

Program Overview

Educating pharmacists on the cancer risks associated with contracting the HPV virus, how the HPV virus is contracted, vaccination recommendations and procedures, and what the pharmacy community can do to promote vaccinations to reduce cancer risks.

Target Audience

Arkansas Pharmacists

Learning Objectives

  • Identify HPV and its link to cancer
  • Review administration of the HPV vaccine using current CDC dosing recommendations
  • Learn how to utilize WebIZ for documentation

Release and Expiration Dates

Release Date: 7/31/20

Expiration Date: 7/31/23

Last Reviewed Date

7/31/20

 

Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by the University of Arkansas for Medical Sciences and Arkansas Immunization Action Coalition. University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ACPE Credit Designation Statement:

These knowledge based activities will provide pharmacists up to 1.0 contact hours or 0.1 CEU. CE credit information, based on verification of live attendance and completion of the program evaluation, will be provided to NABP within 60 days after the activity completion.

Disclosure Policy Statement:

It is the policy of the University of Arkansas for Medical Sciences Office of Continuing Education to ensure balance, independence, objectivity and scientific rigor in all provided and jointly provided educational activities. All individuals who are in a position to control the content of the educational activity (course/activity, directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship. Financial relationships of immediate family members must also be disclosed, if the nature of the relationship(s) could influence the objectivity of the individual in a position to control the content. The ACCME describes relevant financial relationships as those in any amount occurring within the past 12 months that create a conflict of interest. Individuals who refuse to disclose are disqualified from participation in the development, management, presentation, or evaluation of the CE activity.

Planners:
Jeanie Smith, PharmD – Associate Professor and Director of Experiential Education, Harding University; James Narens, PharmD, 2020 Graduate Harding University College of Pharmacy

Peer Reviewer:
Charlie Wright, 1st Year Pharmacy Student, Harding University

Faculty Disclosures:

The planners, speakers, moderators, peer reviewers and /or panelists of this CE activity have no relevant financial relationships with commercial interests to disclose.

References

Schiller, J. T., Day, P. M., & Kines, R. C. (2010). Current understanding of the mechanism of HPV infection. Gynecologic Oncology, 118(1), S12–S17. https://doi.org/10.1016/j.ygyno.2010.04.004

https://www.cancer.org/health-care-professionals/hpv-vaccination-information-for-health-professionals.htm l

https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer

https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer

Xi, L. F., Koutsky, L. A., Castle, P. E., Edelstein, Z. R., Meyers, C., Ho, J., & Schiffman, M. (2009). Relationship Between Cigarette Smoking and Human Papilloma Virus Types 16 and 18 DNA Load. Cancer Epidemiology Biomarkers & Prevention, 18(12), 3490–3496. https://doi.org/10.1158/1055-9965.epi-09-0763

Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., … Goodman, M. T. (2015). US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines. JNCI: Journal of the National Cancer Institute, 107(6). https://doi.org/10.1093/jnci/djv086

Age-Adjusted Invasive Cancer Incidence Rates in Arkansas, 2012 – 2016. Based on data released May 2019. Arkansas Cancer Registry. Cancer-Rates.info. Retrieved Apr 11, 2020, from http://cancer-rates.info/ar/

https://www.aad.org/public/diseases/a-z/genital-warts-treatment

U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on Nov 2018 submission data (1999-2016): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www.cdc.gov/cancer/dataviz  , June 2019.

Burd, Eileen M. Human Papillomavirus and Cervical Cancer Clin Microbiol Rev. 2003 Jan; 16(1): 1–17.

doi: 10.1128/CMR.16.1.1-17.2003 PMCID: PMC145302 PMID: 12525422

Shimabukuro, T. T., Su, J. R., Marquez, P. L., Mba-Jonas, A., Arana, J. E., & Cano, M. V. (2019). Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics, 144(6), e20191791. https://doi.org/10.1542/peds.2019-1791

Donahue, J. G., Kieke, B. A., Lewis, E. M., Weintraub, E. S., Hanson, K. E., McClure, D. L., … Belongia, E. A. (2019). Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics, 144(6), e20191808. https://doi.org/10.1542/peds.2019-1808

https://www.census.gov/quickfacts/geo/chart/AR/IPE120218#IPE120218

Downloads

Presentation

Instructions to obtain credit

  • Launch the activity
  • View the entire activity online
  • Complete the post-test (Must pass the post-test with a score of 80% to receive credit. You may retake the post-test if you do not receive a passing score.)
  • Complete Evaluation

Speaker Bio

Eric Crumbaugh, PharmD

Director of Clinical Business Development at Express Rx in Little Rock. Eric is a member of the Arkansas Pharmacists Association and earned his PharmD from UAMS College of Pharmacy.

Eric Crumbaugh

Contact Information

UAMS Office of Continuing Education

4301 W. Markham #525
Little Rock, AR 72205
Phone: 501-661-7962 Fax: 501-661-7968

Contact Enduring Material Host

ImmunizeAR
417 S. Victory Street, Little Rock, AR 72201
heather@immunizear.org 501-372-6639